DE60131076T2 - Antitumorale verbindungen - Google Patents
Antitumorale verbindungen Download PDFInfo
- Publication number
- DE60131076T2 DE60131076T2 DE60131076T DE60131076T DE60131076T2 DE 60131076 T2 DE60131076 T2 DE 60131076T2 DE 60131076 T DE60131076 T DE 60131076T DE 60131076 T DE60131076 T DE 60131076T DE 60131076 T2 DE60131076 T2 DE 60131076T2
- Authority
- DE
- Germany
- Prior art keywords
- sub
- substituted
- unsubstituted
- nmr
- mhz
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title claims description 49
- 230000000259 anti-tumor effect Effects 0.000 title description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 37
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 29
- 150000003839 salts Chemical class 0.000 claims abstract description 27
- 125000003118 aryl group Chemical group 0.000 claims abstract description 24
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 23
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 19
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 18
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 13
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 11
- 150000002367 halogens Chemical class 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- SYFQZCUQZJXUQE-UHFFFAOYSA-N 4-aminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCCC(O)C(N)CCC SYFQZCUQZJXUQE-UHFFFAOYSA-N 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 5
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- FMUSQJSIDCDCPB-UHFFFAOYSA-N 4-acetamidoicosan-5-yl acetate Chemical compound CCCCCCCCCCCCCCCC(OC(C)=O)C(CCC)NC(C)=O FMUSQJSIDCDCPB-UHFFFAOYSA-N 0.000 claims description 3
- 125000004104 aryloxy group Chemical group 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- RCYFWNYHEBGXJX-UHFFFAOYSA-N 4-aminoicosan-5-one;hydrobromide Chemical compound Br.CCCCCCCCCCCCCCCC(=O)C(N)CCC RCYFWNYHEBGXJX-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- YRYJJIXWWQLGGV-ZWKOTPCHSA-N 1-deoxysphinganine Chemical class CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N YRYJJIXWWQLGGV-ZWKOTPCHSA-N 0.000 abstract description 8
- 125000001072 heteroaryl group Chemical group 0.000 abstract description 3
- 125000001424 substituent group Chemical group 0.000 abstract description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 297
- 238000005481 NMR spectroscopy Methods 0.000 description 242
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 211
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 112
- 238000000034 method Methods 0.000 description 109
- 235000019439 ethyl acetate Nutrition 0.000 description 104
- 239000007787 solid Substances 0.000 description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 55
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 53
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 239000000460 chlorine Substances 0.000 description 47
- 239000000243 solution Substances 0.000 description 46
- 125000004432 carbon atom Chemical group C* 0.000 description 45
- 239000012230 colorless oil Substances 0.000 description 42
- 150000001299 aldehydes Chemical class 0.000 description 33
- 239000000377 silicon dioxide Substances 0.000 description 26
- 238000004440 column chromatography Methods 0.000 description 25
- 150000003462 sulfoxides Chemical class 0.000 description 24
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 23
- 239000012043 crude product Substances 0.000 description 23
- 238000003756 stirring Methods 0.000 description 23
- 239000011541 reaction mixture Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- -1 hydrochloric Chemical class 0.000 description 20
- 239000002904 solvent Substances 0.000 description 17
- 150000002576 ketones Chemical class 0.000 description 14
- 238000000746 purification Methods 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- JKOTZBXSNOGCIF-UHFFFAOYSA-N 1-bromopentadecane Chemical compound CCCCCCCCCCCCCCCBr JKOTZBXSNOGCIF-UHFFFAOYSA-N 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000012267 brine Substances 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 229910010082 LiAlH Inorganic materials 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- JCBPETKZIGVZRE-BYPYZUCNSA-N (2s)-2-aminobutan-1-ol Chemical compound CC[C@H](N)CO JCBPETKZIGVZRE-BYPYZUCNSA-N 0.000 description 2
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 2
- GWXCLXFZVNFRGQ-VQTJNVASSA-N (2s,3r)-2-aminoicosan-3-ol Chemical compound CCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N GWXCLXFZVNFRGQ-VQTJNVASSA-N 0.000 description 2
- UJYQLGQRZHVYGT-RBUKOAKNSA-N (2s,3r)-2-aminononadecan-3-ol Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N UJYQLGQRZHVYGT-RBUKOAKNSA-N 0.000 description 2
- YRYJJIXWWQLGGV-ROUUACIJSA-N (2s,3s)-2-aminooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)N YRYJJIXWWQLGGV-ROUUACIJSA-N 0.000 description 2
- XKMUUIRZUAXHDT-ZWKOTPCHSA-N (3s,4r)-3-aminooctadecan-4-ol Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC XKMUUIRZUAXHDT-ZWKOTPCHSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 2
- HHSDZLLPIXMEIU-UHFFFAOYSA-N 1-bromoheptadecane Chemical compound CCCCCCCCCCCCCCCCCBr HHSDZLLPIXMEIU-UHFFFAOYSA-N 0.000 description 2
- HNTGIJLWHDPAFN-UHFFFAOYSA-N 1-bromohexadecane Chemical compound CCCCCCCCCCCCCCCCBr HNTGIJLWHDPAFN-UHFFFAOYSA-N 0.000 description 2
- KOFZTCSTGIWCQG-UHFFFAOYSA-N 1-bromotetradecane Chemical compound CCCCCCCCCCCCCCBr KOFZTCSTGIWCQG-UHFFFAOYSA-N 0.000 description 2
- IKPSIIAXIDAQLG-UHFFFAOYSA-N 1-bromoundecane Chemical compound CCCCCCCCCCCBr IKPSIIAXIDAQLG-UHFFFAOYSA-N 0.000 description 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 2
- BXRVOOQRCRWPPF-UHFFFAOYSA-N 2-[5-(benzylamino)icosan-4-ylcarbamoyl]benzoic acid Chemical compound C=1C=CC=C(C(O)=O)C=1C(=O)NC(CCC)C(CCCCCCCCCCCCCCC)NCC1=CC=CC=C1 BXRVOOQRCRWPPF-UHFFFAOYSA-N 0.000 description 2
- UITJBVDUQMDHTE-UHFFFAOYSA-N 4-aminoicosan-5-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(O)C(N)CCC UITJBVDUQMDHTE-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 0 CC(*)C(*)*C(N)(N)N Chemical compound CC(*)C(*)*C(N)(N)N 0.000 description 2
- 238000006021 Dakin-West synthesis reaction Methods 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 2
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- COGNMBADMVOOPJ-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-azidooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](N=[N+]=[N-])[C@H](C)NC(=O)OC(C)(C)C COGNMBADMVOOPJ-LEWJYISDSA-N 0.000 description 2
- 150000003512 tertiary amines Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GFYXFRCVQSKSDO-OAHLLOKOSA-N (2r)-2-(dibenzylamino)propanal Chemical compound C=1C=CC=CC=1CN([C@@H](C=O)C)CC1=CC=CC=C1 GFYXFRCVQSKSDO-OAHLLOKOSA-N 0.000 description 1
- CJIILUGXXXKRTA-UNTBIKODSA-N (2r)-2-aminooctadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(=O)[C@@H](C)N CJIILUGXXXKRTA-UNTBIKODSA-N 0.000 description 1
- AUGRPIHBMZBMKB-PPTMTGTBSA-N (2r,3s)-2-(dibenzylamino)octadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@H](C)[C@@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 AUGRPIHBMZBMKB-PPTMTGTBSA-N 0.000 description 1
- YRYJJIXWWQLGGV-MSOLQXFVSA-N (2r,3s)-2-aminooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@@H](C)N YRYJJIXWWQLGGV-MSOLQXFVSA-N 0.000 description 1
- LHAUQAAPXGACHN-XIFFEERXSA-N (2s)-2,5-bis(dibenzylamino)pentan-1-ol Chemical compound C([C@@H](CO)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 LHAUQAAPXGACHN-XIFFEERXSA-N 0.000 description 1
- WUAUOTVCWFISNJ-XIFFEERXSA-N (2s)-2,5-bis(dibenzylamino)pentanal Chemical compound C([C@@H](C=O)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 WUAUOTVCWFISNJ-XIFFEERXSA-N 0.000 description 1
- NEYQXBDXTXAJPH-LJAQVGFWSA-N (2s)-2-(dibenzylamino)-3-(4-phenylmethoxyphenyl)propan-1-ol Chemical compound C([C@@H](CO)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C(C=C1)=CC=C1OCC1=CC=CC=C1 NEYQXBDXTXAJPH-LJAQVGFWSA-N 0.000 description 1
- UBNRYFHVXKUNLV-LJAQVGFWSA-N (2s)-2-(dibenzylamino)-3-(4-phenylmethoxyphenyl)propanal Chemical compound C([C@@H](C=O)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C(C=C1)=CC=C1OCC1=CC=CC=C1 UBNRYFHVXKUNLV-LJAQVGFWSA-N 0.000 description 1
- ZWLAXLXECFRUPM-LJQANCHMSA-N (2s)-2-(dibenzylamino)-3-methylbutan-1-ol Chemical compound C=1C=CC=CC=1CN([C@H](CO)C(C)C)CC1=CC=CC=C1 ZWLAXLXECFRUPM-LJQANCHMSA-N 0.000 description 1
- DIWXTXXLVBAUFO-LJQANCHMSA-N (2s)-2-(dibenzylamino)-3-methylbutanal Chemical compound C=1C=CC=CC=1CN([C@H](C=O)C(C)C)CC1=CC=CC=C1 DIWXTXXLVBAUFO-LJQANCHMSA-N 0.000 description 1
- RWDGCGHIPSWDTF-SFHVURJKSA-N (2s)-2-(dibenzylamino)butan-1-ol Chemical compound C=1C=CC=CC=1CN([C@H](CO)CC)CC1=CC=CC=C1 RWDGCGHIPSWDTF-SFHVURJKSA-N 0.000 description 1
- QJOKRFSPLJVARG-SFHVURJKSA-N (2s)-2-(dibenzylamino)butanal Chemical compound C=1C=CC=CC=1CN([C@H](C=O)CC)CC1=CC=CC=C1 QJOKRFSPLJVARG-SFHVURJKSA-N 0.000 description 1
- XQGBOVZZVRZAPI-IBGZPJMESA-N (2s)-2-(dibenzylamino)pentanal Chemical compound C=1C=CC=CC=1CN([C@H](C=O)CCC)CC1=CC=CC=C1 XQGBOVZZVRZAPI-IBGZPJMESA-N 0.000 description 1
- IEEFFKXJADVWJO-HNNXBMFYSA-N (2s)-2-(dibenzylamino)propan-1-ol Chemical compound C=1C=CC=CC=1CN([C@H](CO)C)CC1=CC=CC=C1 IEEFFKXJADVWJO-HNNXBMFYSA-N 0.000 description 1
- GFYXFRCVQSKSDO-HNNXBMFYSA-N (2s)-2-(dibenzylamino)propanal Chemical compound C=1C=CC=CC=1CN([C@H](C=O)C)CC1=CC=CC=C1 GFYXFRCVQSKSDO-HNNXBMFYSA-N 0.000 description 1
- VJWLDAUJROTQMV-NTISSMGPSA-N (2s)-2-aminoheptadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC(=O)[C@H](C)N VJWLDAUJROTQMV-NTISSMGPSA-N 0.000 description 1
- BVYAQELNVWDOGL-FERBBOLQSA-N (2s)-2-aminononadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCC(=O)[C@H](C)N BVYAQELNVWDOGL-FERBBOLQSA-N 0.000 description 1
- CJIILUGXXXKRTA-LMOVPXPDSA-N (2s)-2-aminooctadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(=O)[C@H](C)N CJIILUGXXXKRTA-LMOVPXPDSA-N 0.000 description 1
- KVTLSBYHFYBBFH-YWPUXERESA-N (2s,3r)-2-(dibenzylamino)-1-(4-phenylmethoxyphenyl)octadecan-3-ol Chemical compound C([C@@H]([C@H](O)CCCCCCCCCCCCCCC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C(C=C1)=CC=C1OCC1=CC=CC=C1 KVTLSBYHFYBBFH-YWPUXERESA-N 0.000 description 1
- CGNUTARTEHVLRP-MSEJLTFDSA-N (2s,3r)-2-(dibenzylamino)docosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 CGNUTARTEHVLRP-MSEJLTFDSA-N 0.000 description 1
- ADEDAWNQSRDQAU-HJIQQCSTSA-N (2s,3r)-2-(dibenzylamino)henicosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 ADEDAWNQSRDQAU-HJIQQCSTSA-N 0.000 description 1
- AMYDWPSWVLJPFG-QCENPCRXSA-N (2s,3r)-2-(dibenzylamino)heptadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCC)CC1=CC=CC=C1 AMYDWPSWVLJPFG-QCENPCRXSA-N 0.000 description 1
- ASXLWVNQVNTGME-BHBYDHKZSA-N (2s,3r)-2-(dibenzylamino)hexadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCC)CC1=CC=CC=C1 ASXLWVNQVNTGME-BHBYDHKZSA-N 0.000 description 1
- KUPBLDFJHZXYHN-AFPLUKJUSA-N (2s,3r)-2-(dibenzylamino)icosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 KUPBLDFJHZXYHN-AFPLUKJUSA-N 0.000 description 1
- IYYPBDNIIAOFBP-BZKUTMRRSA-N (2s,3r)-2-(dibenzylamino)nonadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCC)CC1=CC=CC=C1 IYYPBDNIIAOFBP-BZKUTMRRSA-N 0.000 description 1
- BCRUPINZGODLPA-LITSAYRRSA-N (2s,3r)-2-(dibenzylamino)pentadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCC)CC1=CC=CC=C1 BCRUPINZGODLPA-LITSAYRRSA-N 0.000 description 1
- AZEJZDXDKOWICO-LBNVMWSVSA-N (2s,3r)-2-(dibenzylamino)tetradecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCC)CC1=CC=CC=C1 AZEJZDXDKOWICO-LBNVMWSVSA-N 0.000 description 1
- KOUDXTKPINRAPD-PIZIKKFZSA-N (2s,3r)-2-(dibenzylamino)tricosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 KOUDXTKPINRAPD-PIZIKKFZSA-N 0.000 description 1
- UIUTVIWNQMKVAC-VQTJNVASSA-N (2s,3r)-2-(dimethylamino)octadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N(C)C UIUTVIWNQMKVAC-VQTJNVASSA-N 0.000 description 1
- HLHYZTNWRJAUQR-RBUKOAKNSA-N (2s,3r)-2-(methylamino)octadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC HLHYZTNWRJAUQR-RBUKOAKNSA-N 0.000 description 1
- QZXQYPRJHXBKEW-JHOUSYSJSA-N (2s,3r)-2-amino-1-[tert-butyl(diphenyl)silyl]oxyoctadec-4-en-3-ol Chemical compound C=1C=CC=CC=1[Si](C(C)(C)C)(OC[C@H](N)[C@H](O)C=CCCCCCCCCCCCCC)C1=CC=CC=C1 QZXQYPRJHXBKEW-JHOUSYSJSA-N 0.000 description 1
- HQXBWUOEWTUFST-QZTJIDSGSA-N (2s,3r)-2-amino-1-fluorooctadec-4-en-3-ol Chemical compound CCCCCCCCCCCCCC=C[C@@H](O)[C@H](N)CF HQXBWUOEWTUFST-QZTJIDSGSA-N 0.000 description 1
- HPFJGEIDOJLMHD-QZTJIDSGSA-N (2s,3r)-2-amino-1-fluorooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](N)CF HPFJGEIDOJLMHD-QZTJIDSGSA-N 0.000 description 1
- CFSBBASAHRQSJI-FCHUYYIVSA-N (2s,3r)-2-aminodocosan-3-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N CFSBBASAHRQSJI-FCHUYYIVSA-N 0.000 description 1
- RVJOGGNCBCUJCY-LEWJYISDSA-N (2s,3r)-2-aminohenicosan-3-ol Chemical compound CCCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N RVJOGGNCBCUJCY-LEWJYISDSA-N 0.000 description 1
- JKSGUQAOWIPBPW-MCJVGQIASA-N (2s,3r)-2-aminoheptadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCC[C@@H](O)[C@H](C)N JKSGUQAOWIPBPW-MCJVGQIASA-N 0.000 description 1
- MHXFHHNVWBIFAG-IDVLALEDSA-N (2s,3r)-2-aminohexadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCC[C@@H](O)[C@H](C)N MHXFHHNVWBIFAG-IDVLALEDSA-N 0.000 description 1
- WTBBWNYCZKVGTB-CMXBXVFLSA-N (2s,3r)-2-aminoicosan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N WTBBWNYCZKVGTB-CMXBXVFLSA-N 0.000 description 1
- LZGROQGFXAYCSW-GRTNUQQKSA-N (2s,3r)-2-aminononadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N LZGROQGFXAYCSW-GRTNUQQKSA-N 0.000 description 1
- FAYMLBSNJIKGQB-CJRXIRLBSA-N (2s,3r)-2-aminooctadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N FAYMLBSNJIKGQB-CJRXIRLBSA-N 0.000 description 1
- VOUMNIKAZOWACU-LSDHHAIUSA-N (2s,3r)-2-aminopentadecan-3-ol Chemical compound CCCCCCCCCCCC[C@@H](O)[C@H](C)N VOUMNIKAZOWACU-LSDHHAIUSA-N 0.000 description 1
- IORTZRJPWMLSOC-XZOQPEGZSA-N (2s,3r)-2-aminotricosan-3-ol Chemical compound CCCCCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N IORTZRJPWMLSOC-XZOQPEGZSA-N 0.000 description 1
- GXVBCZQJOQACCC-RBUKOAKNSA-N (2s,3r)-3-methoxyoctadecan-2-amine Chemical compound CCCCCCCCCCCCCCC[C@@H](OC)[C@H](C)N GXVBCZQJOQACCC-RBUKOAKNSA-N 0.000 description 1
- PHSKLFAXXVZHNH-BZKUTMRRSA-N (2s,3r)-n,n-dibenzyl-3-methoxyoctadecan-2-amine Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](OC)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 PHSKLFAXXVZHNH-BZKUTMRRSA-N 0.000 description 1
- HGRNDPZSNAGKAL-OAMYOWMRSA-N (2s,3r)-octadecane-2,3-diamine;dihydrochloride Chemical compound Cl.Cl.CCCCCCCCCCCCCCC[C@@H](N)[C@H](C)N HGRNDPZSNAGKAL-OAMYOWMRSA-N 0.000 description 1
- CVEDEXBVZHXRAU-FXAWDEMLSA-N (2s,3s)-2-(dibenzylamino)-3-methylpentanal Chemical compound C=1C=CC=CC=1CN([C@H](C=O)[C@@H](C)CC)CC1=CC=CC=C1 CVEDEXBVZHXRAU-FXAWDEMLSA-N 0.000 description 1
- YYNGDOQMKFCVKA-NYDCQLBNSA-N (2s,3s)-n,n-dibenzyl-3-chlorooctadecan-2-amine Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@@H](Cl)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 YYNGDOQMKFCVKA-NYDCQLBNSA-N 0.000 description 1
- 239000001618 (3R)-3-methylpentan-1-ol Substances 0.000 description 1
- NRFLLXAELPLZCW-OIDHKYIRSA-N (3s,4r)-3-(dibenzylamino)henicosan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 NRFLLXAELPLZCW-OIDHKYIRSA-N 0.000 description 1
- HLJJMLAPCTXGLG-SZAHLOSFSA-N (3s,4r)-3-(dibenzylamino)icosan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCCCC)CC1=CC=CC=C1 HLJJMLAPCTXGLG-SZAHLOSFSA-N 0.000 description 1
- GOCTYZBUNUKUFQ-JHOUSYSJSA-N (3s,4r)-3-(dibenzylamino)nonadecan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 GOCTYZBUNUKUFQ-JHOUSYSJSA-N 0.000 description 1
- HRGLQWXSKJTKIJ-AJQTZOPKSA-N (3s,4r)-3-(dibenzylamino)octadecan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCC)CC1=CC=CC=C1 HRGLQWXSKJTKIJ-AJQTZOPKSA-N 0.000 description 1
- VVCPIYXWLZVSBR-UXHICEINSA-N (3s,4r)-3-amino-2-methylnonadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)C(C)C VVCPIYXWLZVSBR-UXHICEINSA-N 0.000 description 1
- VQNVWFLKOKFHHQ-FDOHDBATSA-N (3s,4r)-3-amino-2-methylnonadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)C(C)C VQNVWFLKOKFHHQ-FDOHDBATSA-N 0.000 description 1
- PSXKECHGVVRCNA-LEWJYISDSA-N (3s,4r)-3-aminohenicosan-4-ol Chemical compound CCCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC PSXKECHGVVRCNA-LEWJYISDSA-N 0.000 description 1
- ONKPNJONCBZRDY-JUDYQFGCSA-N (3s,4r)-3-aminohenicosan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC ONKPNJONCBZRDY-JUDYQFGCSA-N 0.000 description 1
- YHDSKQMWOBVXCK-VQTJNVASSA-N (3s,4r)-3-aminoicosan-4-ol Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC YHDSKQMWOBVXCK-VQTJNVASSA-N 0.000 description 1
- HCLFEEHNUHFUFS-CMXBXVFLSA-N (3s,4r)-3-aminoicosan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC HCLFEEHNUHFUFS-CMXBXVFLSA-N 0.000 description 1
- LBMMFFUIESTUET-RBUKOAKNSA-N (3s,4r)-3-aminononadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC LBMMFFUIESTUET-RBUKOAKNSA-N 0.000 description 1
- BYRQRAPUQDAMQM-GRTNUQQKSA-N (3s,4r)-3-aminononadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC BYRQRAPUQDAMQM-GRTNUQQKSA-N 0.000 description 1
- IGWJJOINJMHRBX-CJRXIRLBSA-N (3s,4r)-3-aminooctadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC IGWJJOINJMHRBX-CJRXIRLBSA-N 0.000 description 1
- LBMMFFUIESTUET-OALUTQOASA-N (3s,4s)-3-aminononadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CC LBMMFFUIESTUET-OALUTQOASA-N 0.000 description 1
- LVOOZEPWURRJNZ-MYZAEBQFSA-N (3s,4s,5r)-4-(dibenzylamino)-3-methylicosan-5-ol Chemical compound C=1C=CC=CC=1CN([C@@H]([C@@H](C)CC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 LVOOZEPWURRJNZ-MYZAEBQFSA-N 0.000 description 1
- LDKKSOGAGPATOF-NFQNBQCWSA-N (3s,4s,5r)-4-amino-3-methylicosan-5-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)CC LDKKSOGAGPATOF-NFQNBQCWSA-N 0.000 description 1
- XHBYXJQGBOESGC-JYHRMSDVSA-N (4s,5r)-1,4-bis(dibenzylamino)icosan-5-ol Chemical compound C([C@@H]([C@H](O)CCCCCCCCCCCCCCC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 XHBYXJQGBOESGC-JYHRMSDVSA-N 0.000 description 1
- WNYPMOAMZYEYQQ-VQTJNVASSA-N (4s,5r)-1,4-diaminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCCN WNYPMOAMZYEYQQ-VQTJNVASSA-N 0.000 description 1
- MJRCXRGIFFFXRP-SZAHLOSFSA-N (4s,5r)-4-(dibenzylamino)icosan-5-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CCC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 MJRCXRGIFFFXRP-SZAHLOSFSA-N 0.000 description 1
- SYFQZCUQZJXUQE-VQTJNVASSA-N (4s,5r)-4-aminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCC SYFQZCUQZJXUQE-VQTJNVASSA-N 0.000 description 1
- YGFQERDVWZDGKR-ZWKOTPCHSA-N (4s,5r)-4-methyl-5-pentadecyl-1,3-oxazolidin-2-one Chemical compound CCCCCCCCCCCCCCC[C@H]1OC(=O)N[C@H]1C YGFQERDVWZDGKR-ZWKOTPCHSA-N 0.000 description 1
- HGQSKTQYEWJJRZ-SNAWJCMRSA-N (e)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl chloride Chemical compound FC(F)(F)C1=CC=CC(\C=C\C(Cl)=O)=C1 HGQSKTQYEWJJRZ-SNAWJCMRSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 1
- GWESGLGUMMNXDU-UHFFFAOYSA-N 1-bromononadecane Chemical compound CCCCCCCCCCCCCCCCCCCBr GWESGLGUMMNXDU-UHFFFAOYSA-N 0.000 description 1
- WSULSMOGMLRGKU-UHFFFAOYSA-N 1-bromooctadecane Chemical compound CCCCCCCCCCCCCCCCCCBr WSULSMOGMLRGKU-UHFFFAOYSA-N 0.000 description 1
- BFDNZQUBFCYTIC-UHFFFAOYSA-N 1-bromotridecane Chemical compound CCCCCCCCCCCCCBr BFDNZQUBFCYTIC-UHFFFAOYSA-N 0.000 description 1
- WMUMHAZHWIUBPN-UONOGXRCSA-N 1-deoxytetradecasphinganine Chemical compound CCCCCCCCCCC[C@@H](O)[C@H](C)N WMUMHAZHWIUBPN-UONOGXRCSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ZPPANEJYFOVYGD-RBUKOAKNSA-N 2,2,2-trifluoro-n-[(2s,3r)-3-hydroxynonadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)C(F)(F)F ZPPANEJYFOVYGD-RBUKOAKNSA-N 0.000 description 1
- RZEBFQUQWLEGQB-ZWKOTPCHSA-N 2,2,2-trifluoro-n-[(2s,3r)-3-hydroxyoctadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)C(F)(F)F RZEBFQUQWLEGQB-ZWKOTPCHSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- QMJQSFDECLZDKQ-BJKOFHAPSA-N 4-[(2s,3r)-2-amino-3-hydroxyoctadecyl]phenol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC1=CC=C(O)C=C1 QMJQSFDECLZDKQ-BJKOFHAPSA-N 0.000 description 1
- OJEXGSVEJWYOTI-KZDWWKKTSA-N 4-[(2s,3r)-2-amino-3-hydroxyoctadecyl]phenol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC1=CC=C(O)C=C1 OJEXGSVEJWYOTI-KZDWWKKTSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000011057 Breast sarcoma Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- XFLRQZAWHWSVGT-QYFCPYRKSA-N CCCCCCCCCCCCCCC[C@H]([C@H](C)NC(/C=C/c1cc(C(F)(F)F)ccc1)=O)O Chemical compound CCCCCCCCCCCCCCC[C@H]([C@H](C)NC(/C=C/c1cc(C(F)(F)F)ccc1)=O)O XFLRQZAWHWSVGT-QYFCPYRKSA-N 0.000 description 1
- GZCOKUJKSQHJLP-LADGPHEKSA-N CCCCCCCCCCCCCCC[C@H]([C@H](C)NC(Nc1ccccc1)=O)O Chemical compound CCCCCCCCCCCCCCC[C@H]([C@H](C)NC(Nc1ccccc1)=O)O GZCOKUJKSQHJLP-LADGPHEKSA-N 0.000 description 1
- WPAVHKMJWQCKLE-NSHDSACASA-N CCC[C@@H](C(OCc1ccccc1)=O)N Chemical compound CCC[C@@H](C(OCc1ccccc1)=O)N WPAVHKMJWQCKLE-NSHDSACASA-N 0.000 description 1
- ZOTYRCXAYNESOX-BYPYZUCNSA-N CC[C@@H](CN=O)N Chemical compound CC[C@@H](CN=O)N ZOTYRCXAYNESOX-BYPYZUCNSA-N 0.000 description 1
- QCAAXUQRSHUEHU-NTSWFWBYSA-N CC[C@H](C)[C@@H](C=O)N Chemical compound CC[C@H](C)[C@@H](C=O)N QCAAXUQRSHUEHU-NTSWFWBYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 125000000030 D-alanine group Chemical class [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- VDRZDTXJMRRVMF-UONOGXRCSA-N D-erythro-sphingosine Natural products CCCCCCCCCC=C[C@@H](O)[C@@H](N)CO VDRZDTXJMRRVMF-UONOGXRCSA-N 0.000 description 1
- 244000089409 Erythrina poeppigiana Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 229910004161 SiNa Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000237543 Spisula Species 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- BYXJPMAYVVLAHT-BFGHFXMOSA-N [(2s,3r)-2-(dibenzylamino)octadecan-3-yl] acetate Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](OC(C)=O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 BYXJPMAYVVLAHT-BFGHFXMOSA-N 0.000 description 1
- GIIJVODZLVLEGD-JTHBVZDNSA-N [(2s,3r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]octadecan-3-yl] acetate Chemical compound CCCCCCCCCCCCCCC[C@@H](OC(C)=O)[C@H](C)NC(=O)OC(C)(C)C GIIJVODZLVLEGD-JTHBVZDNSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- HRLVFAFZMYZQDA-VWLOTQADSA-N benzyl (2s)-2-(dibenzylamino)pentanoate Chemical compound C=1C=CC=CC=1CN([C@@H](CCC)C(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 HRLVFAFZMYZQDA-VWLOTQADSA-N 0.000 description 1
- YOGRASYHFHYDTH-NVQXNPDNSA-N benzyl (2s,3s)-2-(dibenzylamino)-3-methylpentanoate Chemical compound C=1C=CC=CC=1CN([C@@H]([C@@H](C)CC)C(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 YOGRASYHFHYDTH-NVQXNPDNSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- SBWYBQRWDXWJDV-NSHDSACASA-N benzyl n-[(2s)-1-hydroxybutan-2-yl]carbamate Chemical compound CC[C@@H](CO)NC(=O)OCC1=CC=CC=C1 SBWYBQRWDXWJDV-NSHDSACASA-N 0.000 description 1
- AFPHMHSLDRPUSM-VIFPVBQESA-N benzyl n-[(2s)-1-hydroxypropan-2-yl]carbamate Chemical compound OC[C@H](C)NC(=O)OCC1=CC=CC=C1 AFPHMHSLDRPUSM-VIFPVBQESA-N 0.000 description 1
- XTXJPZGMVKIPHE-VIFPVBQESA-N benzyl n-[(2s)-1-oxopropan-2-yl]carbamate Chemical compound O=C[C@H](C)NC(=O)OCC1=CC=CC=C1 XTXJPZGMVKIPHE-VIFPVBQESA-N 0.000 description 1
- DEUQDTOHXOPYNC-ZCYQVOJMSA-N benzyl n-[(2s,3s)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)NC(=O)OCC1=CC=CC=C1 DEUQDTOHXOPYNC-ZCYQVOJMSA-N 0.000 description 1
- ACAVESYJEZZZBO-UIOOFZCWSA-N benzyl n-[(3s,4s)-4-hydroxynonadecan-3-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](CC)NC(=O)OCC1=CC=CC=C1 ACAVESYJEZZZBO-UIOOFZCWSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- CNWSQCLBDWYLAN-UHFFFAOYSA-N butylurea Chemical compound CCCCNC(N)=O CNWSQCLBDWYLAN-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000010893 malignant breast melanoma Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- DWKPPFQULDPWHX-GSVOUGTGSA-N methyl (2r)-2-aminopropanoate Chemical compound COC(=O)[C@@H](C)N DWKPPFQULDPWHX-GSVOUGTGSA-N 0.000 description 1
- AZGMGUYPTZUDQG-XIFFEERXSA-N methyl (2s)-2,5-bis(dibenzylamino)pentanoate Chemical compound C([C@@H](C(=O)OC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 AZGMGUYPTZUDQG-XIFFEERXSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WDKILEMZUUOOCY-AZUAARDMSA-N n-[(2s,3r)-3-hydroxyoctadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(C)=O WDKILEMZUUOOCY-AZUAARDMSA-N 0.000 description 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- WMYNHKOXVHXIGA-RTWAWAEBSA-N tert-butyl N-[(4S,5R)-1,1,1-trifluoro-5-hydroxy-2-oxoicosan-4-yl]oxycarbamate Chemical compound C(C)(C)(C)OC(=O)NO[C@@H](CC(C(F)(F)F)=O)[C@@H](CCCCCCCCCCCCCCC)O WMYNHKOXVHXIGA-RTWAWAEBSA-N 0.000 description 1
- QCAKWVLMNAWRQB-HXUWFJFHSA-N tert-butyl n-[(2r)-3-oxooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@@H](C)NC(=O)OC(C)(C)C QCAKWVLMNAWRQB-HXUWFJFHSA-N 0.000 description 1
- KWSHECYEOCFPKT-IBGZPJMESA-N tert-butyl n-[(2s)-3-oxoheptadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C KWSHECYEOCFPKT-IBGZPJMESA-N 0.000 description 1
- XYDOOIXHMORPDI-NRFANRHFSA-N tert-butyl n-[(2s)-3-oxononadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C XYDOOIXHMORPDI-NRFANRHFSA-N 0.000 description 1
- QCAKWVLMNAWRQB-FQEVSTJZSA-N tert-butyl n-[(2s)-3-oxooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C QCAKWVLMNAWRQB-FQEVSTJZSA-N 0.000 description 1
- ROXXCXTYCKNKSQ-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-aminooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](N)[C@H](C)NC(=O)OC(C)(C)C ROXXCXTYCKNKSQ-LEWJYISDSA-N 0.000 description 1
- GHCSSUVLZCQDRS-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)OC(C)(C)C GHCSSUVLZCQDRS-LEWJYISDSA-N 0.000 description 1
- ROXXCXTYCKNKSQ-SFTDATJTSA-N tert-butyl n-[(2s,3s)-3-aminooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](N)[C@H](C)NC(=O)OC(C)(C)C ROXXCXTYCKNKSQ-SFTDATJTSA-N 0.000 description 1
- GHCSSUVLZCQDRS-SFTDATJTSA-N tert-butyl n-[(2s,3s)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)NC(=O)OC(C)(C)C GHCSSUVLZCQDRS-SFTDATJTSA-N 0.000 description 1
- QLERQMHCZMGTNX-NRFANRHFSA-N tert-butyl n-[(3s)-4-oxononadecan-3-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@H](CC)NC(=O)OC(C)(C)C QLERQMHCZMGTNX-NRFANRHFSA-N 0.000 description 1
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
- C07C225/06—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0013783 | 2000-06-06 | ||
| GB0013783A GB0013783D0 (en) | 2000-06-06 | 2000-06-06 | New antitumoral derivatives of spisulosine-285 |
| GB0102472 | 2001-01-31 | ||
| GB0102472A GB0102472D0 (en) | 2001-01-31 | 2001-01-31 | New antitumoral derivatives of spisulosine-285 |
| GB0104732A GB0104732D0 (en) | 2001-02-26 | 2001-02-26 | New antitumoral derivatives of spisulosine-285 |
| GB0104732 | 2001-02-26 | ||
| PCT/GB2001/002487 WO2001094357A1 (en) | 2000-06-06 | 2001-06-06 | Antitumoral compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60131076D1 DE60131076D1 (de) | 2007-12-06 |
| DE60131076T2 true DE60131076T2 (de) | 2008-07-31 |
Family
ID=27255753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60131076T Expired - Lifetime DE60131076T2 (de) | 2000-06-06 | 2001-06-06 | Antitumorale verbindungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7138547B2 (enExample) |
| EP (1) | EP1287006B1 (enExample) |
| JP (1) | JP2003535868A (enExample) |
| AT (1) | ATE376552T1 (enExample) |
| AU (2) | AU6251801A (enExample) |
| BR (1) | BR0111505A (enExample) |
| CA (1) | CA2410409A1 (enExample) |
| DE (1) | DE60131076T2 (enExample) |
| ES (1) | ES2293996T3 (enExample) |
| IL (2) | IL153096A0 (enExample) |
| MX (1) | MXPA02012121A (enExample) |
| WO (1) | WO2001094357A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003005965A2 (en) * | 2001-07-11 | 2003-01-23 | Musc Foundation For Research Development | Modulators of ceramidase and methods of use based thereon |
| FR2847473B1 (fr) * | 2002-11-25 | 2007-06-29 | Expanscience Lab | Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament |
| US7960589B2 (en) * | 2006-09-06 | 2011-06-14 | Emory University | Synthesis of sphingosines and their derivatives |
| US8431733B2 (en) * | 2008-03-12 | 2013-04-30 | Virobay, Inc. | Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives |
| WO2014118556A2 (en) * | 2013-01-31 | 2014-08-07 | Research Foundation Of The City University Of New York | Selective inhibitors and allosteric activators of sphingosine kinase |
| JP6661192B2 (ja) * | 2016-01-19 | 2020-03-11 | 国立大学法人北海道大学 | Sms2阻害活性を有するセラミド誘導体 |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB546383A (en) * | 1940-10-08 | 1942-07-10 | Frank Lodge | New wool dyestuffs |
| US2399118A (en) | 1942-02-13 | 1946-04-23 | Mallinckrodt Chemical Works | 2-oxazolidone compounds and method for preparing the same |
| US2363082A (en) * | 1943-01-20 | 1944-11-21 | Novocol Chemical Mfg Co Inc | Anesthetic compounds, intermediates, and processes therefor |
| US2424311A (en) * | 1943-11-10 | 1947-07-22 | Merck & Co Inc | Process for making esters of 7,8-diamino nonoic acid |
| DE828547C (de) * | 1949-08-21 | 1952-01-17 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von Komplexsalzbildnern |
| GB1057651A (en) * | 1963-01-16 | 1967-02-08 | Merck & Co Inc | Chlorinated amino acids and their preparation |
| GB1433920A (en) | 1973-10-01 | 1976-04-28 | Ici Ltd | Alkanolamine derivatives |
| US6800661B1 (en) * | 1997-04-15 | 2004-10-05 | Board Of Trustees Of The University Of Illinois | Spisulosine compounds |
| US6107520A (en) * | 1997-04-15 | 2000-08-22 | The Board Of Trustees Of The University Of Illinois | Spisulosine compounds |
| US6756504B2 (en) * | 2000-04-19 | 2004-06-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sphingolipids |
| EP1363643A2 (en) * | 2000-12-22 | 2003-11-26 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| JP3692492B2 (ja) * | 2001-05-01 | 2005-09-07 | 独立行政法人科学技術振興機構 | 新規なスフィンゴ脂質合成阻害剤 |
| WO2003045928A1 (en) * | 2001-11-26 | 2003-06-05 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| BR0205172A (pt) * | 2001-12-20 | 2004-06-29 | Cosmoferm Bv | Processo para a sìntese de esfingosina |
-
2001
- 2001-06-06 CA CA002410409A patent/CA2410409A1/en not_active Abandoned
- 2001-06-06 EP EP01936649A patent/EP1287006B1/en not_active Expired - Lifetime
- 2001-06-06 AT AT01936649T patent/ATE376552T1/de not_active IP Right Cessation
- 2001-06-06 ES ES01936649T patent/ES2293996T3/es not_active Expired - Lifetime
- 2001-06-06 BR BR0111505-7A patent/BR0111505A/pt not_active IP Right Cessation
- 2001-06-06 AU AU6251801A patent/AU6251801A/xx active Pending
- 2001-06-06 MX MXPA02012121A patent/MXPA02012121A/es active IP Right Grant
- 2001-06-06 DE DE60131076T patent/DE60131076T2/de not_active Expired - Lifetime
- 2001-06-06 IL IL15309601A patent/IL153096A0/xx unknown
- 2001-06-06 JP JP2002501905A patent/JP2003535868A/ja active Pending
- 2001-06-06 US US10/297,352 patent/US7138547B2/en not_active Expired - Fee Related
- 2001-06-06 AU AU2001262518A patent/AU2001262518B2/en not_active Ceased
- 2001-06-06 WO PCT/GB2001/002487 patent/WO2001094357A1/en not_active Ceased
-
2002
- 2002-11-26 IL IL153096A patent/IL153096A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1287006A1 (en) | 2003-03-05 |
| DE60131076D1 (de) | 2007-12-06 |
| ATE376552T1 (de) | 2007-11-15 |
| WO2001094357A1 (en) | 2001-12-13 |
| BR0111505A (pt) | 2003-06-24 |
| IL153096A (en) | 2007-09-20 |
| AU6251801A (en) | 2001-12-17 |
| EP1287006B1 (en) | 2007-10-24 |
| CA2410409A1 (en) | 2001-12-13 |
| AU2001262518B2 (en) | 2006-10-26 |
| MXPA02012121A (es) | 2003-06-06 |
| IL153096A0 (en) | 2003-06-24 |
| JP2003535868A (ja) | 2003-12-02 |
| ES2293996T3 (es) | 2008-04-01 |
| US7138547B2 (en) | 2006-11-21 |
| US20040048834A1 (en) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69915470T2 (de) | Neue 3-aryl-2-hydroxypropionsäure-derivate iii | |
| EP0657440A1 (de) | Oxazolidin-2-on-Derivate | |
| DE2430237A1 (de) | Aethanolaminderivate und verfahren zur herstellung derselben | |
| DE69618663T2 (de) | O-carbamoyl-phenylalaninol-zusammensetzungen und ihre pharmazeutisch anwendbaren salzen | |
| DE60131076T2 (de) | Antitumorale verbindungen | |
| DE69103535T2 (de) | 1-Phenylalkyl-3-Phenylharnstoff-Derivate. | |
| AU2001262518A1 (en) | Antitumoral compounds | |
| DE102006059317A1 (de) | Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden | |
| DE2921057B2 (de) | Optisch aktive Oxazaphosphorinderivate, Verfahren zur Herstellung derselben und deren Verwendung | |
| DE69604642T2 (de) | Verfahren zur herstellung von iodierten kontrastmitteln | |
| DE68901792T2 (de) | Phenoxyethylamin derivate, verfahren zu ihrer herstellung und zusammensetzungen, die sie enthalten, und alpha-1-blockeraktivitaet. | |
| DE69829654T2 (de) | Verfahren zur herstellung von rhizoferrin | |
| DE69611286T2 (de) | Neue sulfamate mit n-substituierten carbamoyl-gruppen und verfahren zu deren herstellung | |
| JP4084855B2 (ja) | 環式化合物の製法 | |
| EP0005192B1 (de) | Alkylaminopropanolderivate von 3-Alkyl-5-(2-hydroxystyryl)-isoxazolen, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| DE2126169C3 (de) | Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen | |
| FI66856B (fi) | Foerfarande foer framstaellning av nya hjaertstimulerande alkanolaminderivat | |
| EP0511558B1 (de) | Racemat-Spaltverfahren und diastereomere Assoziate | |
| EP0027978B1 (de) | Neue Aminoderivate des 5-(2-Hydroxystyryl)-isoxazols, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| DE3734219C2 (enExample) | ||
| DE2308943A1 (de) | Herbizide verbindungen | |
| DE2944222A1 (de) | Neue aminoderivate des 1,2-benzisothiazols | |
| DE69302889T2 (de) | p-[Di(2-Chloroethyl)amino]phenylalanin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| EP0265388A1 (de) | Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung | |
| EP0008108A2 (de) | Aminopropanolderivate des 2-(o-Hydroxyphenyl)-pyrrols, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8381 | Inventor (new situation) |
Inventor name: ACENA, JOSE LUIS, TRES CANTOS, E-28760 MADRID, ES Inventor name: ADRIO, JAVIER, TRES CANTOS, E-28760 MADRID, ES Inventor name: CUEVAS, CARMEN, TRES CANTOS, E-28760 MADRID, ES Inventor name: GALLEGO, PILAR, TRES CANTOS, E-28760 MADRID, ES Inventor name: MANZANARES, IGNACIO, TRES CANTOS, E-28760 MADR, ES Inventor name: MUNT, SIMON, TRES CANTOS, E-28760 MADRID, ES Inventor name: RODRIGUEZ, IGNACIO, TRES CANTOS, E-28760 MADRI, ES |
|
| 8364 | No opposition during term of opposition |